DEL PHARMACEUTICALS AGREES TO PRE-SCREEN AURO-DRI STUDY SUBJECTS
This article was originally published in The Tan Sheet
Executive Summary
DEL PHARMACEUTICALS AGREES TO PRE-SCREEN AURO-DRI STUDY SUBJECTS for history of water-clogged ears, the company told FDA during a May 27 "OTC feedback" meeting in Rockville, Md. The company said it plans to submit, "as soon as possible," a protocol to test the efficacy of Auro-Dri (95% isopropyl alcohol in anhydrous glycerin) in relieving water-clogged ears.